The initiation of a pilot clinical trial of OXPzeroTM Ibuprofen is a positive step and follows the successful development of a chewable form of OXPzeroTM Ibuprofen in May 2015. Headline PK data is expected in July 2015 and endoscopy data late Q3/early Q4. The group also expects to announce headline data from its OXPzeroTM Naproxen endoscopy trial by the end of July 2015. NSAIDs represent one of the most widely used drug classes in the world, but their use is associated with GI side effects. The ....

16 Jul 2015
Initiation of OXPzeroTM Ibuprofen pilot clinical trial

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Initiation of OXPzeroTM Ibuprofen pilot clinical trial
Abaco Capital (ABA:LON) | 0 0 -2.9% | Mkt Cap: 16.9m
- Published:
16 Jul 2015 -
Author:
Singer CM Team -
Pages:
3 -
The initiation of a pilot clinical trial of OXPzeroTM Ibuprofen is a positive step and follows the successful development of a chewable form of OXPzeroTM Ibuprofen in May 2015. Headline PK data is expected in July 2015 and endoscopy data late Q3/early Q4. The group also expects to announce headline data from its OXPzeroTM Naproxen endoscopy trial by the end of July 2015. NSAIDs represent one of the most widely used drug classes in the world, but their use is associated with GI side effects. The ....